Sleep Medicine
Volume 10, Issue 4 , Pages 403-404 , April 2009

Rebound cataplexy after withdrawal from antidepressants

Received 17 June 2008 ,Accepted 26 June 2008.

References 

  1. Akimoto H, Honda Y, Takahashi Y. Pharmacotherapy in narcolepsy. Dis Nerv Syst. 1960;21:704–706
  2. Hishikawa Y, et al. Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran). J Neurol Sci. 1966;3(5):453–461
  3. Passouant P, Baldy-Moulinier M, Aussilloux C. Cataplexy associated with Gelineau’s disease; effect of clomipramine. Rev Neurol (Paris). 1970;123(1):56–60
  4. Guilleminault C, Wilson RA, Dement WC. A study on cataplexy. Arch Neurol. 1974;31(4):255–261
  5. Passouant P, Baldy-Moulinier M, Aussilloux C. Etat de mal cataplectique au cours d’une maladie de Gelineau – influence de la clomipramine. Rev Neurol (Paris). 1970;123:56–60
  6. Guilleminault C, et al. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand. 1976;54(1):71–87
  7. Parkes JD, Schachter M. Clomipramine and clonazepam in cataplexy. Lancet. 1979;2(8151):1085–1086
  8. Gelb M, et al. Stability of cataplexy over several months – information for the design of therapeutic trials. Sleep. 1994;17(3):265–273
  9. Krahn LE, et al. A standardized test for cataplexy. Sleep Med. 2000;1(2):125–130

PII: S1389-9457(08)00163-9

doi: 10.1016/j.sleep.2008.06.004

Sleep Medicine
Volume 10, Issue 4 , Pages 403-404 , April 2009

Article Tools